O
BDSI

OppenheimerFunds’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

OppenheimerFunds’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-430,530
Closed -$5.17M – 1011
2014
Q4 		$5.17M Buy
430,530
+143,510
+50% +$2.18M 0.01% 823
2014
Q3 		$4.91M Buy
+287,020
New +$4.17M 0.01% 837

Other funds holding BDSI

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds's BDSI Position: Q1 2015 in Review

OppenheimerFunds sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2015, closing a stake of 430,530 shares — an estimated $5.17M sold.

OppenheimerFunds first reported a position in BDSI in Q3 2014 and held it in 2 quarters. The position peaked at $5.17M in Q4 2014. 147 funds tracked by Wall St. Rank hold BDSI as of Q1 2015.

  • OppenheimerFunds reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 430,530 BioDelivery Sciences International, Inc. shares in Q1 2015, an estimated $5.17M.
  • OppenheimerFunds first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 2 quarters.
  • OppenheimerFunds's BioDelivery Sciences International, Inc. position peaked at $5.17M in Q4 2014.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.